• 1
    Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998;279:12001205.
  • 2
    Vervloet D & Durham S. Adverse reactions to drugs. BMJ 1998;316:15111514.
  • 3
    Demoly P, Hillaire-Buys D, Blayac JP, Godard Ph, Michel FB, Bousquet J. Global burden of drug allergy. ACI News 1999;6:201207.
  • 4
    Kraft D, Hedin H, Richter N, Scheiner O, Rumpold H, Devey M. Immunoglobulin class and subclass distribution of dextran reactive antibodies in human reactors and nonreactors to clinical dextran. Allergy 1982;37:481489.
  • 5
    Blanca M, Perez E, Garcia J, et al. Anaphylaxis to amoxicillin but good tolerance for benzyl penicillin. In vivo and in vitro studies of specific IgE antibodies. Allergy 1988;43:508510.
  • 6
    Vervloet D, Aranud A, Senft M, et al. Leukocyte histamine release to suxamethonium in patients with adverse reactions to muscle relaxants. J Allergy Clin Immunol 1985;75:338342.
  • 7
    Demoly P, Lebel B, Messaad D, et al. Predictive capacity of histamine release for the diagnosis of drug allergy. Allergy 1999;55:500506.
  • 8
    De Weck AL. Cellular allergen stimulation test (CAST): a new dimension in allergy diagnostics. ACI News 1993;1/5:914.
  • 9
    Kubota Y, Imayama S, Toshitani A, et al. Sulfidoleukotriene release test (CAST) in hypersensitivity to nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 1997;114:361366.
  • 10
    Watkins J & Wild G. Improved diagnosis of anaphylactoid reactions by measurement of serum tryptase and urinary methylhistamine. Ann Fr Anesth Reanim 1993;12:169172.
  • 11
    Fernandez J, Blanca M, Moreno F, et al. Role of tryptase, eosinophil cationic protein and histamine in immediate allergic reactions to drugs. Int Arch Allergy Immunol 1995;107:160162.
  • 12
    Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991;88:328338.
  • 13
    Nyfeler B & Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1996;27:175181.
  • 14
    Bischoff SC, Brunner T, De Weck AL, Dahinden CA. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 1990;172:15771583.
  • 15
    Demoly P, Messaad D, Sahla H, Hillaire-Buys D, Bousquet J. Immediate hypersensitivity to ceftriaxone. Allergy 2000;55:418419.DOI: 10.1034/j.1398-9995.2000.00605.x
  • 16
    Morel A, Darmon M, Delaage M. Immunoassay for histamine. Agents Actions 1990;30:291293.
  • 17
    Koller DY, Rosenkranz AR, Pirker C, Götz M, Jarisch R. Assessment of histamine release from basophils in whole blood by benzylpenicilloyl poly-l-lysine in penicillin-sensitized patients. Allergy 1992;47:459462.
  • 18
    Galen RS & Gambino SR. Beyond normality, the predictive value and efficiency of medical devices. New York: Wiley, 1975.
  • 19
    Szczeklik A & Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:513.
  • 20
    Sanz ML, Sanchez G, Vila L, Dieguez I, Oehling AK. Antigen-specific sulfidoleukotriene production in allergy to β-lactam antibiotics. Int Arch Allergy Immunol 1999;118:364365.
  • 21
    Czech W, Schopf E, Kapp A. Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm Res 1995;44:291295.
  • 22
    May A, Weber A, Gall H, Kaufmann R, Zollner MZ. Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance. Clin Exp Allergy 1999;20:14021411.
  • 23
    Patterson R, DeSwarte RD, Greenberger PA, Grammer LC, Brown JE, Choy AC. Drug allergy and protocols for management of drug allergies. 2nd ed. Providence, RI: Ocean Side Publications, 1995.
  • 24
    Blanca M, Torres MJ, Garcia JJ, et al. Natural evolution of skin test sensitivity in patients allergic to β-lactam antibiotics. J Allergy Clin Immunol 1999;103:918924.